Poolbeg expands POLB 001 into oncology

In Depth 5 Jan 2023

Navignostics maps tumor proteomes to improve precision oncology

Laevoroc Oncology pushes for relapsed leukemia cure

Partnership to deliver oncology workflow for 7 European hospitals


Alkermes to separate oncology business

First patient dosed in trial to assess predictive performance of immuno-oncology therapy

Odyssey Therapeutics raises $168M for oncology medicine portfolio

Beyond Biotech podcast 15: Cullinan Oncology, Pleco Therapeutics, TikoMed

Aktis Oncology raises millions in funding bringing total to $161M

Sanofi and Innovent Biologics to collaborate on oncology medicines and boost China presence

Ipsen and Marengo Therapeutics partner to push immuno-oncology candidates into the clinic

BioMed X Institute and Merck start new oncology research project